U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Optimizing the Use of Real-World Evidence in Regulatory Decision-Making for Drugs and Biological Products - 12/12/2024
  1. Drugs

Public | Mixed

Event Title
Optimizing the Use of Real-World Evidence in Regulatory Decision-Making for Drugs and Biological Products
December 12, 2024

Scheduled
Date:
December 12, 2024
Time:
12:30 p.m. - 4:30 p.m. ET

FDA announces public workshop on optimizing use of real-world evidence – looking forward 

The U.S. Food and Drug Administration is announcing a free public workshop that will focus on recent accomplishments, ongoing opportunities & challenges, and forward-looking initiatives regarding FDA’s Real-World Evidence Program for drugs and biological products. 

This public workshop will discuss potential next steps to promote the continued evolution and consistent application of real-world data in drug development. The public workshop will be convened and supported by a cooperative agreement between FDA and the Duke-Margolis Institute for Health Policy at Duke University. 

This hybrid workshop will be Thursday, December 12, 2024, from 12:30 p.m. to 4:30 p.m. (ET), and we encourage in-person participation. Please register by Friday, December 6, 2024. Registration is free and based on available space due to limited seating. Early registrants will have priority. 

Back to Top